1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Epiomic Epidemiology Series: Symptomatic Vitreomacular Adhesion Forecast in 9 Major Markets 2016-2026

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Symptomatic Vitreomacular Adhesion in 9 Major Markets

Symptomatic Vitreomacular adhesion (VMA) is a rare macular condition caused by an incomplete posterior vitreous detachment from the retina, located at the back of the eye, with remaining vitreomacular attachment and unperturbed foveal morphologic features. It is almost always the result of normal vitreous aging, and is termed symptomatic VMA leading to vitreomacular traction because with loss of vitreous volume, these areas of VMA exert a “pulling force” on the macula, causing other pathologic conditions.

This report provides the current prevalent population for symptomatic VMA across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of VMA have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for VMA include:

-Decreased visual acuity
-Retinal distortion and disruption
-Post-menopause (females)
-Macular oedema
-Macular hole
-Myopia
-Diabetes

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global symptomatic VMA’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of symptomatic VMA and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on symptomatic VMA’s prevalent population.
-Identify sub-populations within symptomatic VMA which require treatment.
-Gain an understanding of the specific markets that have the largest number symptomatic VMA patients.

Table Of Contents

Epiomic Epidemiology Series: Symptomatic Vitreomacular Adhesion Forecast in 9 Major Markets 2016-2026
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis and Clinical Course
-Key Co-morbid Conditions/ Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line Prevalence for Symptomatic VMA
-Main Complications and Features of Symptomatic Vitreomacular Patients
o The presence of Symptomatic VMA in Age-related Macular Degeneration (AMD)
o Diameter of adhesion in Symptomatic VMA
o Prevalence of Co-morbidities in Symptomatic VMA Patients
-Abbreviations used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix


List of Tables and Figures
-Prevalence of Symptomatic VMA, total (000s)
-Prevalence of Symptomatic VMA, males (000s)
-Prevalence of Symptomatic VMA, females (000s)
-Symptomatic VMA by morphology, total (000s)
-Prevalence of Isolated Symptomatic VMA and Concurrent VMA, total (000s)
-Focal and Broad Symptomatic VMA, total (000s)
-Prevalence of Decreased VA in Symptomatic VMA patients, total (000s)
-Prevalence of RD and Disruption in Symptomatic VMA patients, total (000s)
-Prevalence of DR in Symptomatic VMA patients, total (000s)
-Prevalence of Macular Oedema in Symptomatic VMA patients, total (000s)
-Prevalence of DME in Symptomatic VMA patients, total (000s)
-Prevalence of Macular Hole in Symptomatic VMA patients, total (000s)
-Abbreviations and Acronyms used in the Report
-USA Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-USA Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-France Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-France Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-Germany Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-Germany Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-Italy Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-Italy Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-Spain Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-Spain Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-Brazil Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-Brazil Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-Japan Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-Japan Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)
-India Prevalence of Symptomatic VMA by 5-yr age cohort, males (000s)
-India Prevalence of Symptomatic VMA by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Influenza Statistics in the US

  • November 2016
    6 pages
  • Infectious Dise...  

    Influenza  

  • United States  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Global Eye Disease Statistics

  • November 2016
    7 pages
  • Eye Disease  

  • World  

    Tanzania  

View report >

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.